Key facts
- Adiposs’s last known valuation is $48.8M (Dec 2021).
- It has raised $7.3M; the latest was Later Stage VC ($4.9M) in Jul 2025.
- Notable investors include MassChallenge, Venture Kick, Kickfund, Kingbridge, CR Ventures (Acquired in 2022) — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Adiposs
- ·The full record, as it builds
Funding rounds
No funding rounds for Adiposs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Adiposs
Developer of medical imaging products and technologies designed for the early detection of cachexia, a devastating body-wasting syndrome. The company's CT contrast product can detect body wasting early, before weight loss, a year earlier, enabling hospitals and healthcare providers to detect cancer early, improve patients' quality of life, and give them a better chance to survive cancer and other chronic diseases.
- Sector
- Healthcare
- HQ
- Geneva, Switzerland
- Founded
- 2004
- Employees
- 6
- Website
- adiposs.com/
- Ownership
- Privately Held (backing)
Adiposs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Adiposs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Adiposs in its N-PORT filings yet. We sweep new filings monthly.